Several HDAC inhibitors can reverse the unfavorable impact of the loss of MHCII expression20, and chidamide was reported to significantly enhance rituximab‐induced tumor growth inhibition in vitro and in vivo.21 The gene discussed is HDAC9; the disease is neoplasm.